Showing results (91-100 of 1,520) with videos related to
Sort By:
Pageof 152
CPT: Pharmacometrics & Systems Pharmacology|October 21, 2023
A convolution-based in vitro-in vivo correlation model for methylphenidate hydrochloride delayed-release and extended-release capsulePawan Kumar Gupta, Bev Incledon, Jogarao V S Gobburu, et al.CPT: Pharmacometrics & Systems Pharmacology|October 10, 2023
A multicompartment population PK model to predict tenofovir and emtricitabine mucosal tissue concentrations for HIV preventionErick Leung, Mackenzie L Cottrell, Craig Sykes, et al.CPT: Pharmacometrics & Systems Pharmacology|October 5, 2023
Applied physiologically-based pharmacokinetic modeling to assess uridine diphosphate-glucuronosyltransferase-mediated drug-drug interactions for VericiguatSebastian Frechen, Ibrahim Ince, André Dallmann, et al.CPT: Pharmacometrics & Systems Pharmacology|October 6, 2023
Physiologically-based pharmacokinetic model to predict doxorubicin and paclitaxel exposure in infants through breast milkDavid Damoiseaux, Frédéric Amant, Jos H Beijnen, et al.CPT: Pharmacometrics & Systems Pharmacology|September 22, 2023
Physiologically based mechanistic insight into differential risk of valproate hepatotoxicity between children and adults: A focus on ontogeny impactYu-Ting Huang, Yen-Ming Huang, Fan-Lu Kung, et al.CPT: Pharmacometrics & Systems Pharmacology|July 19, 2023
Longitudinal efficacy and safety modeling and simulation framework to aid dose selection of belantamab mafodotin for patients with multiple myelomaJon Collins, Martijn van Noort, Chetan Rathi, et al.CPT: Pharmacometrics & Systems Pharmacology|June 30, 2023
Copanlisib population pharmacokinetics from phase I-III studies and exposure-response relationships in combination with rituximabPeter N Morcos, Jonathan Moss, Rupert Austin, et al.CPT: Pharmacometrics & Systems Pharmacology|July 14, 2023
Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modelingAnna M Mc Laughlin, Peter A Milligan, Cassian Yee, et al.CPT: Pharmacometrics & Systems Pharmacology|July 27, 2023
Exposure-safety and exposure-efficacy analyses for tisotumab vedotin for patients with locally advanced or metastatic solid tumorsChaitali Passey, Jenna Voellinger, Leonid Gibiansky, et al.CPT: Pharmacometrics & Systems Pharmacology|July 26, 2023
Saliva as a noninvasive sampling matrix for therapeutic drug monitoring of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation: A prospective population pharmacokinetic and simulation studyBaohua Xu, Ting Yang, Jianxing Zhou, et al.Pageof 152